BreastfeedingTENDERNCT07569172

Improved Child Nutrition and Development Through Social Transfers

A study testing Social Transfer in people with Breastfeeding and Breastfeeding Education, run by Swiss Tropical & Public Health Institute at 1 site in Côte d’Ivoire.

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts

Official record

Search all trials

Trial summary

The goal of this clinical trial is to learn if a conditional social transfer works to improve rates of complementary breastfeeding. It will also learn about the impacts of social transfers on maternal and child health and development. Read more about this study

Who is it for?: Ages 12 years and older, women only
Conditions the study is for: Breastfeeding, Breastfeeding Education, Breastfeeding Duration
What is being tested?: Social Transfer
Could I receive a placebo?: No, everyone receives an active treatment
How many people: 1,040 participants
Where: 1 siteCôte d’Ivoire
Study dates: 1 Jun 2026to 28 Feb 2028
Phase: Interventional

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

Ages 12 years and older
Women only
No healthy volunteers
Child, Adult, Older adult

Who may be able to join

Are enrolled in the Taabo multigenerational birth cohort (MGC)
Completed the postpartum interview of the Taabo MGC
Have a child who is within two weeks of their 12-month birthday,
are breastfeeding at time of recruitment,
live in the Taabo HDSS, Côte d'Ivoire
have no illnesses that contraindicates breastfeeding,
had a healthy singleton infant with a birth weight of at least 2500 grams, and
agree to participate and sign an informed consent; if underage (12-17 years), a legal representative will also have to agree to sign the informed consent

Who cannot join

Plans to move permanently outside study area
Has a medical, intellectual or psychological disability
Contraindication for breastfeeding
Children born with < 2500 grams

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Côte d’Ivoire1 site

Taabo Health and Demographic Surveillance
Taabo
Siaka Koné, +225 0749069627, Siaka.kone@csrs.ci

Other trials in Côte d’Ivoire

About this study

Official title: Taabo Enhanced Nutrition and Development Through Economic Rewards

Does the social transfer increase complementary breastfeeding rates at 24-months postpartum?
Does the social transfer increase complementary breastfeeding duration?
Does the social transfer impact child health and development?
Does the social transfer impact maternal physical and mental health?

Researchers will compare a conditional social transfer to a control group that only receives education about breastfeeding recommendations to see if a conditional social transfers works to increase complementary breastfeeding.

Participants will:

Receive a pamphlet explaining the current recommendations of breastfeeding Receive instructions that if they meet the recommendation to breastfeed until 24-months postpartum they receive a social transfer or receive no additional information Complete home visits at 12- and 24-months postpartum Complete detailed questionnaire

Conditions: Breastfeeding, Breastfeeding Education, Breastfeeding Duration, Breastfeeding Continuation, Child Growth, Stress
Being tested: Social Transfer
Keywords: breastfeeding, cash transfer, child health, maternal health, mental health, child growth, child development, education
Medical subject headings: Breast Feeding, Communicable Diseases, Anemia, Weight Loss, Psychological Well-Being, Diarrhea, Cough, Eczema

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

Social TransferOther
A social transfer will be given conditioned upon breastfeeding at 24-months postpartum.

Study groups in NCT07569172
Study group	Role	What they receive
Social Transfer	Experimental	A social transfer is provided at the 24-month visit, conditional on the mother still breastfeeding at the time of the visit. They also receive education about current breastfeeding recommendations. Receives: Other: Social Transfer
Control	No intervention	No intervention is provided besides education on current breastfeeding recommendations.

What is being measured

The primary outcome is the main question the study is designed to answer.

Prevalence of Complementary Breastfeeding
Prevalence of complementary breastfeeding at 24 months postpartum.
Measured: from 12 to 24 months postpartum
Complementary Breastfeeding Duration
Duration of complementary breastfeeding in weeks.
Measured: from 12 to 24 months postpartum

Secondary outcomes (16)

Weight-for-Age z-score
Infants will be weighed in kilograms by a mobile weighing scale. Measurements will be analyzed as age standardized z-scores.
Measured: 12 months; 24 months
Child Health Outcomes
We will assess the child's health outcomes by using a questionnaire administered to the caregiver. The questionnaire will ask a range of yes or no questions about child diarrhea, respiratory illness, fever, and child antibiotic use.
Measured: 12 months; 24 months
Percent weight loss
Percent weight loss will use body weight (kg) and pregnancy weight of the mother controlling for time of measurement. Percent weight loss will be calculated as ((current weight - pregnancy weight) / pregnancy weight) × 100.
Measured: 12 months; 24 months;
Mother and Child Hemoglobin Levels
We will assess the mother and child anemia levels. The HemoCue Hb 301 will be used to give an instant measurement of the Haemoglobin (Hb) level of the patient. Capillary blood will be collected through a finger prick. Blood samples drawn for the haemoglobin assessment will be discarded after the test. Iron levels will be analyzed as a continuous outcome.
Measured: 12 months; 24 months
Maternal Depression
Maternal postpartum depression will be assessed using the Patient Health Questionnaire-9 (PHQ-9); categorized as a binary: no depression (score <10) or depression present (score ≥10).
Measured: 12 months; 24 months
Height-for-age z-score
Height will be measured in centimeters by using a Height Measuring Device, stadiometer, 20-205cm. All measurements will be analyzed as age standardized z-scores
Measured: 12 months; 24 months
Mid-upper arm circumference (MUAC)
Infants will be measured for mid-upper arm circumference (MUAC) using non-stretchable measuring tape. All measurements will be analyzed as age standardized z-scores.
Measured: 12 months; 24 months
Mother and Child Anemia
The HemoCue Hb 301 will be used to give an instant measurement of the Haemoglobin (Hb) level of the patient. Capillary blood will be collected through a finger prick. Blood samples drawn for the haemoglobin assessment will be discarded after the test. Hemoglobin levels (gm/dL) will be used to categorize mothers and children into a binary variable: anemic or not anemic.
Measured: 12 months; 24 months
Maternal weight change
Weight weight change will use body weight (kg) and pregnancy weight of the mother controlling for time of measurement. Maternal weight change will be calculated as the difference between postpartum weight and pregnancy weight. Because pregnancy weight varies by gestational age, analyses will control for gestational age at pregnancy weight measurement and time postpartum at outcome measurement.
Categorized as: no weight loss (0 kg); moderate weight loss (<0 to >-5 kg); high weight loss (≥-5 kg); moderate weight gain (>0 to <5 kg); high weight gain (≥5 kg).
Measured: 12 months; 24 months;
Change in systolic and diastolic blood pressure (mmHg)
Change in systolic and diastolic blood pressure (mmHg) from baseline of the mothers will be categorized as low, normal, or high according to standard clinical thresholds.
Measured: 12 months; 24 months;
Change in systolic and diastolic blood pressure (mmHg)
Change in systolic and diastolic blood pressure (mmHg) from baseline of the mothers will be analyzed as a continuous measure.
Measured: 12 months; 24 months;
Caregiver Reported Early Development Instruments (CREDI) cognitive z-score
The CREDI long-form will be administered. Raw item data will be converted to norm-referenced z-scores using the CREDI scoring procedure.
Measured: 12 months; 24 months
CREDI language z-score
The CREDI long-form will be administered. Raw item data will be converted to norm-referenced z-scores using the CREDI scoring procedure.
Measured: 12 months; 24 months
CREDI motor z-score
The CREDI long-form will be administered. Raw item data will be converted to norm-referenced z-scores using the CREDI scoring procedure.
Measured: 12 months; 24 months
CREDI social-emotional z-score
The CREDI long-form will be administered. Raw item data will be converted to norm-referenced z-scores using the CREDI scoring procedure.
Measured: 12 months; 24 months
Maternal Anxiety
Maternal postpartum anziety will be assessed using the the GAD-7 (Generalized Anxiety Disorder-7); a seven-item self-report questionnaire designed to measure the severity of anxiety; categorized as: Minimal Anxiety: score 0-4; Mild Anxiety: score 5-9; Moderate Anxiety: score 10-14; Severe Anxiety: score 15-21
Measured: 12 months; 24 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

1 Jun 202628 Feb 2028

First posted6 May 2026
Study start1 Jun 2026 (estimated)
Primary completion28 Feb 2028 (estimated)
Study completion28 Feb 2028 (estimated)

Resources

Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
Other trials for BreastfeedingStudies of the same condition, open and under way.
What the trial phases meanHow a treatment moves from first tests in people to approval.

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design

Study type: Interventional
Phase: Phase N/A
Primary purpose: Other
Allocation: Randomised
Intervention model: Parallel groups
Masking: None (open label)
Enrolment: 1,040 participants (estimated)

IDs, dates and publications

ClinicalTrials.gov ID: NCT07569172
Sponsor's protocol ID: 2025-50
Acronym: TENDER
Status last verified: Apr 2026
First submitted: 15 Apr 2026
Last updated: 6 May 2026
Results posted: No
Data monitoring committee: No
FDA-regulated drug: No
FDA-regulated device: No
Individual data sharing: Yes

Interested in taking part?

Each site lists its own contact. Pick the site nearest to you.

Talk to your doctor first and take this page with you. Only the study team can confirm whether you can join.

Questions to ask the study team

What is the study trying to find out?
What would I need to do, and how often would I visit?
Could I receive a placebo instead of the treatment?
What are the possible risks and benefits for me?
Will it cost me anything? Are travel or time paid for?
Can I keep seeing my own doctor during the study?
What happens when the study ends?

See sites and contacts

RecruitingObservational study
Experiences of Mothers Considering Breastfeeding Cessation: Decision-Making, Method Exploration, and Support Needs
Breastfeeding Cessation
Recruiting
Methyl Donor-Rich Diet in the Postpartum Period
Postpartum Depression (PPD), Breastfeeding
Not yet recruiting
Postpartum Care in the NICU Multi-Site Breastfeeding
Postpartum Complication, Postpartum
Not yet recruiting
Effects of Maternal and Infant Massage on Breastfeeding and Mother-Infant Bonding
Breastfeeding, Mother-Infant Bonding
Recruiting
Relaxation Intervention to Improve Newborn Growth and Maternal Well-being
Well-Being, Psychological, Breastfeeding

All Breastfeeding trials